Production of a cgmp batch of triapine injection
Ended Awarded Last action
- Contract number
- 75N91021F00062
- Awardee
-
Societal Cdmo San Diego, LLC UEI YRPTVKHDL7Z5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $249,950
Award facts
- Opportunity
-
- TORFPDCTD20210101 Solicitation number
- Contract value 100% obligated
- $249,950.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6850 Miscellaneous Chemical Specialties
- Set-aside
- Partial Small Business
- Competition
- Full and Open Competition after exclusion of sources · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$1 | |
| Other Administrative Action | $0 | |
| Original award | $249,951 |
About this award
This is a $249,950.42 firm fixed-price delivery order awarded to Societal CDMO San Diego, LLC (doing business as Irisys Inc.) by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract is for the production of a current Good Manufacturing Practices (cGMP) batch of Triapine injection, a novel anticancer drug. This order was placed under the $45 million Drug Formulation and Manufacturing Contracts 2019 Indefinite Delivery/Indefinite Quantity (IDIQ) vehicle, through which Societal CDMO provides product development services across oral, injectable, and topical dosage forms to support NCI's translational research and clinical studies. The contract has a partial small business set-aside.
Quick answers
Who was awarded contract 75N91021F00062?
75N91021F00062 was awarded to Societal Cdmo San Diego, LLC by National Cancer Institute (National Institutes of Health) on February 22, 2021.
How much is contract 75N91021F00062 worth?
The government has obligated $249,950 on 75N91021F00062.
Is contract 75N91021F00062 an order under another contract?
Yes. 75N91021F00062 is a delivery order under 75N98019D00058, an indefinite delivery contract, on Drug Formulation and Manufacturing Contracts 2019.
Was contract 75N91021F00062 competed?
The extent of competition for 75N91021F00062 was full and open competition after exclusion of sources. The government received 3 offers. It was set aside: Partial Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award